Term
|
Definition
| ~Primary neurotransmitter of the parasympathetic nervous system; also present at somatic neuromuscular junctions and at sympathetic preganglionic nerves |
|
|
Term
| Acetylcholinesterase (AchE) |
|
Definition
| ~Enzyme that degrades acetylcholine within the synaptic cleft, enhancing effects of the neurtransmitter |
|
|
Term
|
Definition
| ~Relating to nerves that release norepinephrine or epinephrine |
|
|
Term
|
Definition
| ~Drug that blocks the actions of the sympathetic nervous system |
|
|
Term
| Alpha Receptor (a receptor) |
|
Definition
| ~Type of subreceptor found in the sympathetic nervous system |
|
|
Term
|
Definition
~Drug that blocks the actions of the parasympathetic nervous system
~parasympatholytic
~cholinergic or muscarinic blockers |
|
|
Term
| Autonomic Nervous System (ANS) |
|
Definition
| ~Portion of the peripheral nervous system that governs involuntary actions of the smooth muscle, cardiac muscle, and glands |
|
|
Term
| Beta Receptor (B receptor) |
|
Definition
| ~Type of subreceptor found in the sympathetic nervous system |
|
|
Term
|
Definition
| ~Class of agents secreted in response to stress that include epinephrine, norepinephrine, and dopamine |
|
|
Term
| Central Nervous System (CNS) |
|
Definition
| ~Division of the nervous system consisting of the brain and spinal cord |
|
|
Term
|
Definition
| ~Relating to nerves that release acetylcholine |
|
|
Term
|
Definition
| ~Characteristic set of signs and symptoms produced when the sympathetic nervous system is activated |
|
|
Term
|
Definition
| ~Region where 2 neurons meet in a ganglion |
|
|
Term
|
Definition
| ~Enzyme that destroys norepinephrine in the nerve terminal |
|
|
Term
|
Definition
| ~Type of cholinergic receptor found in smooth muscle, cardiac muscle, and glands |
|
|
Term
|
Definition
| ~Motor disorder caused by a destruction of nicotinic receptors on skeletal muscles and characterized by profound muscular fatigue |
|
|
Term
|
Definition
| ~Type of cholinergic receptor found in ganglia of both the sympathetic and parasympathetic nervous systems |
|
|
Term
|
Definition
| ~Primary neurotransmitter in the sympathetic nervous system |
|
|
Term
| Parasympathetic Nervous System (PNS) |
|
Definition
| ~Portion of the autonomic nervous system that is active during periods of rest and results in the rest, digest, relax response |
|
|
Term
|
Definition
~Drug that mimics the actions of the parasympathetic nervous system
~cholinergic
~produce rest and digest |
|
|
Term
| Peripheral Nervous System (PNS) |
|
Definition
| ~Division of the nervous system containing all nervous tissue outside the CNS, including the autonomic nervous system |
|
|
Term
|
Definition
| ~Neuron that receives an action potential from a preganglionic neuron |
|
|
Term
|
Definition
| ~Neuron that creates an action potential and sends it to a postganglionic neuron |
|
|
Term
|
Definition
| ~Signs and symptoms produced when the parasympathetic nervous system is activated |
|
|
Term
|
Definition
| ~Nerve division that provides voluntary control over skeletal muscle |
|
|
Term
| Sympathetic Nervous System (SNS) |
|
Definition
| ~Portion of the autonomic system that is active during periods of stress and results in the fight or flight response |
|
|
Term
|
Definition
~Drug that inhibits the sympathetic nervous system; actions opposite of sympathomimetic functions of the body
~directly inhibits FOF
~adrenergic blocker |
|
|
Term
|
Definition
~Drug that stimulates or mimics the sympathetic nervous system
~produce fight or flight |
|
|
Term
|
Definition
| ~Junction between 2 neurons consisting of a presynaptic nerve, a synaptic cleft, and postsynaptic nerve |
|
|
Term
|
Definition
| ~Process by which a neurotransmitter reaches receptors to regenerate the action potential |
|
|
